Plasmid-encoded gene duplications of extended-spectrum β-lactamases in clinical bacterial isolates
Frontiers in Cellular and Infection Microbiology · 2024
DOI: 10.3389/fcimb.2024.1343858 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2024. Verfasst von Annika Sobkowiak und 6 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Hygiene, University Hospital Münster, Münster, Germany. Hauptthemen laut MEDLINE: Ceftazidime, Anti-Bacterial Agents. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
The emergence of extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae is an urgent and alarming One Health problem. This study aimed to investigate duplications of plasmid-encoded ESBL genes and their impact on antimicrobial resistance (AMR) phenotypes in clinical and screening isolates.
Methods
Multi-drug-resistant bacteria from hospitalized patients were collected during routine clinical surveillance from January 2022 to June 2023, and their antimicrobial susceptibility patterns were determined. Genotypes were extracted from long-read whole-genome sequencing data. Furthermore, plasmids and other mobile genetic elements associated with ESBL genes were characterized, and the ESBL genes were correlated to ceftazidime minimal inhibitory concentration (MIC).
Results
In total, we identified four cases of plasmid-encoded ESBL gene duplications that match four genetically similar plasmids during the 18-month surveillance period: five Escherichia coli and three Klebsiella pneumoniae isolates. As the ESBL genes were part of transposable elements, the surrounding sequence regions were duplicated as well. In-depth analysis revealed insertion sequence (IS)-mediated transposition mechanisms. Isolates with duplicated ESBL genes exhibited a higher MIC for ceftazidime in comparison to isolates with a single gene copy (3–256 vs. 1.5–32 mg/L, respectively).
Conclusion
ESBL gene duplications led to an increased phenotypic resistance against ceftazidime. Our data suggest that ESBL gene duplications by an IS-mediated transposition are a relevant mechanism for how AMR develops in the clinical setting and is part of the microevolution of plasmids.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Hygiene, University Hospital Münster, Münster, Germany.
- Department of Cardiology I - Coronary and Peripheral Vascular Disease, Heart Failure, University Hospital Münster, Münster, Germany.
- Institute of Medical Microbiology, University Hospital Münster, Münster, Germany.
Zitieren
APA
Sobkowiak, A., Scherff, N., Schuler, F., Bletz, S., Mellmann, A., Schwierzeck, V., & van Almsick, V. (2024). Plasmid-encoded gene duplications of extended-spectrum β-lactamases in clinical bacterial isolates. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2024.1343858
Vancouver
Sobkowiak A, Scherff N, Schuler F, Bletz S, Mellmann A, Schwierzeck V, et al. Plasmid-encoded gene duplications of extended-spectrum β-lactamases in clinical bacterial isolates. Frontiers in Cellular and Infection Microbiology. 2024. doi:10.3389/fcimb.2024.1343858
BibTeX
@article{Sobkowiak2024,
author = {Sobkowiak, Annika and Scherff, Natalie and Schuler, Franziska and Bletz, Stefan and Mellmann, Alexander and Schwierzeck, Vera and van Almsick, Vincent},
title = {Plasmid-encoded gene duplications of extended-spectrum β-lactamases in clinical bacterial isolates},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2024},
doi = {10.3389/fcimb.2024.1343858}
}
EUVIMED